Description
Chimeric antigen receptor T cells (CAR-T) are produced from a patient’s own Tcells in order more actively engage the immune system in cancer treatment. The CAR-T production process is highly complex and assays are not currently available t…
Amendment chain · 2 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $217,525 at start, $217,525 after amendment #1 (+$0).
- #02023-01-01$217,525
- #12024-12-05$217,525
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2023-01-01(start date) | $217,525 | — | Chimeric antigen receptor T cells (CAR-T) are produced from a patient’s own Tcells in order more actively eng… |
| #1 amendment | 2024-12-05 | $217,525 | +$0 | Chimeric antigen receptor T cells (CAR-T) are produced from a patient’s own Tcells in order more actively eng… |
Related records · 11
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 119259505)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2025-2026-Q4-1040854 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives | $277,599 | FY2026 |
| 172-2025-2026-Q1-1029941 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives | $328,966 | FY2026 |
| 172-2024-2025-Q3-1023488 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives | $175,702 | FY2025 |
| 271-2024-2025-Q3-00051 | Health Canada | Santé Canada · Substance Use and Addictions Program | $196,656 | FY2025 |
| 271-2025-2026-Q3-00042 | Health Canada | Santé Canada · Substance Use and Addictions Program | $246,656 | FY2025 |
| 172-2023-2024-Q4-1015832 | National Research Council Canada | Conseil national de recherches Canada · Collaborative Science, Technology and Innovation Program – Ideation Fund | $25,000 | FY2024 |
Other recipients funded under "Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2026-2027-Q1-1044103 | York University | FY2027 | $462,000 | FY2027 |
| 172-2026-2027-Q1-1043787 | Simon Fraser University | FY2027 | $279,766 | FY2027 |
| 172-2026-2027-Q1-1044229 | Noram Electrolysis Systems Inc. | FY2027 | $300,053 | FY2027 |
| 172-2026-2027-Q1-1043305 | University of Ottawa | FY2027 | $418,000 | FY2027 |
| 172-2026-2027-Q1-1043602 | University of Windsor | FY2027 | $99,000 | FY2027 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2022-2023-Q4-1000406 · retrieved 2026-11-14.